UA4433U - Method for correcting latent disturbances of carbohydrate metabolism in experimental animals - Google Patents

Method for correcting latent disturbances of carbohydrate metabolism in experimental animals

Info

Publication number
UA4433U
UA4433U UA20040503505U UA2004503505U UA4433U UA 4433 U UA4433 U UA 4433U UA 20040503505 U UA20040503505 U UA 20040503505U UA 2004503505 U UA2004503505 U UA 2004503505U UA 4433 U UA4433 U UA 4433U
Authority
UA
Ukraine
Prior art keywords
disturbances
latent
correcting
experimental animals
carbohydrate metabolism
Prior art date
Application number
UA20040503505U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Любов Валеріївна Тихохід
Тетяна Ананіївна Золотарьова
Татьяна Ананьевна Золотарёва
Борис Абдулайович Насібуллін
Борис Абдуллаевич Насибуллин
Олексій Якович Олешко
Олена Іванівна Бахолдіна
Елена Ивановна Бахолдина
Аля Сергіївна Ручкіна
Олена Самуілівна Павлова
Наталія Олексіївна Алексєєнко
Сергій Геннадійович Гуща
Сергей Геннадьевич Гуща
Original Assignee
Український Науково-Дослідний Інститут Медичної Реабілітації Та Курортології
Украинский Научно-Исследовательский Институт Медицинской Реабилитации И Курортологии
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Український Науково-Дослідний Інститут Медичної Реабілітації Та Курортології, Украинский Научно-Исследовательский Институт Медицинской Реабилитации И Курортологии filed Critical Український Науково-Дослідний Інститут Медичної Реабілітації Та Курортології
Priority to UA20040503505U priority Critical patent/UA4433U/en
Publication of UA4433U publication Critical patent/UA4433U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The method for correcting the latent disturbances of the carbohydrate metabolism in the experimental animals with pre-diabetes comprises the oral administration of hydrocarbonate-chloride, chloride-hydrocarbonate, magnesium-calcium-sodium silicic mineral water "Dana". The water is administered daily.
UA20040503505U 2004-05-11 2004-05-11 Method for correcting latent disturbances of carbohydrate metabolism in experimental animals UA4433U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA20040503505U UA4433U (en) 2004-05-11 2004-05-11 Method for correcting latent disturbances of carbohydrate metabolism in experimental animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA20040503505U UA4433U (en) 2004-05-11 2004-05-11 Method for correcting latent disturbances of carbohydrate metabolism in experimental animals

Publications (1)

Publication Number Publication Date
UA4433U true UA4433U (en) 2005-01-17

Family

ID=74348001

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20040503505U UA4433U (en) 2004-05-11 2004-05-11 Method for correcting latent disturbances of carbohydrate metabolism in experimental animals

Country Status (1)

Country Link
UA (1) UA4433U (en)

Similar Documents

Publication Publication Date Title
BRPI0415639A (en) once daily controlled release oxycodone oral dosage forms
YU30004A (en) Use of flibanserin in the treatment of sexual disorders
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
NZ595526A (en) Pharmaceutical composition comprising a vla-4 binding antibody, a phosphate buffer and a surfactant
NZ709704A (en) Protein formulations and methods of making same
MX2009011755A (en) Combination therapy with a compound acting as a platelet adp receptor inhibitor.
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
TW200505900A (en) Muscarinic agonists
EP1781277A4 (en) A combination composition
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
HK1049284A1 (en) Benzimidazole compounds having nociceptin receptoraffinity
BR0316305A (en) A compound or a pharmaceutically acceptable salt thereof, methods for treating pain in an animal, for stimulating opioid receptor function in a cell, for preparing a composition, and for treating diarrhea in an animal, composition, and kit.
MX2007004120A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens.
CA2632207C (en) Use of calcitonin for the treatment of ra
GB2352972A (en) Use of dexmedetomidine for icu sedation
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
UA4433U (en) Method for correcting latent disturbances of carbohydrate metabolism in experimental animals
MY142076A (en) Emulsifying systems containing azetidine derivatives
EP1622450A4 (en) Method for promoting uninterrupted sleep by administration of trospium chloride
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
BR0309684A (en) Treatment of pain with ifendropil
RS95204A (en) Combination for the treatment of airway disorders
UA89020C2 (en) Method for the preparartion of a clarithromycin tablet core, a core and a pharmaceutical composition